Tocilizumab is a humanized monoclonal antibody that neutralizes the interleukin-6 receptor (IL-6R), inhibiting both classical and trans IL-6 signaling pathways. It is a critical research tool for studying inflammatory diseases like rheumatoid arthritis and has been investigated in clinical research for severe COVID-19 cytokine storm.
Concentration:
21.5 mg/mL
Molecular Weight:
148 kDa
Purity:
99.50% (May vary between batches)
CAS Number:
[375823-41-9]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted